Identification of factors associated with impaired hypoglycaemia awareness in patients with type 1 and type 2 diabetes mellitus

Diabetes and Metabolism

Volumn 31, Issue 3 I, 2005, Pages 246-251

  Berlin, I ^a   Sachon, C I ^a   Grimaldi, A ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Hypoglycaemia unawareness; Smoking; Type 1 diabetes; Type 2 diabetes

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; INSULIN;

ADULT; AGE; AGED; AWARENESS; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DROWSINESS; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NERVOUSNESS; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; RISK FACTOR; SELF REPORT; SMOKING; SYMPTOMATOLOGY; TREMOR;

EID: 21844463552     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70191-X     Document Type: Article

References (28)

1. Cryer PE. Hypoglycemia: the limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia, 2002, 45, 937-48.
2. Smith D, Amiel SA. Hypoglycaemia unawareness and the brain. Diabetologia, 2002, 45, 949-58.
3. Cryer PE. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med, 2004, 350, 2272-9.
4. Hoeldtke RD, Boden G. Epinephrine secretion, hypoglycemia unawareness, and diabetic autonomic neuropathy. Ann Intern Med, 1994, 120, 512-7.
5. Berlin I, Grimaldi A, Payan C, et al. Hypoglycemic symptoms and decreased beta-adrenergic sensitivity in insulin-dependent diabetic patients. Diabetes Care, 1987; 10: 742-7.
6. Berlin I, Grimaldi A, Landault C, Zoghbi F, Thervet F, Legrand JC. Lack of hypoglycemic symptoms and decreased beta-adrenergic sensitivity in insulin-dependent diabetic patients. J Clin Endocrinol Metab, 1988, 66, 273-7.
7. Korytkowski MT, Mitrakou A, Mokan M, Cryer PE, Veneman TF, Gerich JE. Reduced beta-adrenergic sensitivity in patients with type 1 diabetes and hypoglycemia unawareness. Diabetes Care, 1998, 21, 1939-43.
8. Fritsche A, Stumvoll M, Grub M, et al. Effect of hypoglycemia on beta-adrenergic sensitivity in normal and type 1 diabetic subjects. Diabetes Care, 1998, 21, 1505-10.
9. Seltzer HS. Drug-induced hypoglycemia. A review of 1418 cases. Endocrinol Metab Clin North Am, 1989, 18, 163-83.
10. Veneman TF, Erkelens DW. Hypoglycemia unawareness in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab, 1997, 82, 1682-4.
11. Lustman P, Anderson R, Freedland K, et al. Depression and poor glycaemic control: a meta-analytic review of the literature. Diabetes Care, 2000, 23, 934-42.
12. Eiber R, Berlin I, Bisserbe JC, et al. Diabète insulino-dependant et pathologic psychiatrique: revue générale clinique et épidémiologique. L'Encéphale, 1997, 23, 351-7.
13. Ismail K, Winkley K, Rabe-Hesketh S. Systematic review and meta-analysis of randomised controlled trials of psychological intervention to improve glycaemic control in patients with type 2 diabetes. Lancet, 2004, 363, 1589-97.
14. Chalon S, Berlin I, Sachon C, et al. Propranolol in hypoglycemia unawareness. Diabetes Metab, 1999, 25, 23-6.
15. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry, 1961, 4, 561-71.
16. Chapman LJ, Chapman JP, Raulin ML. Scales for physical and social anhedonia. J Abnormal Psychology, 1976, 85, 374-82.
17. Baylé FJ, Bourdel MC, Caci H, et al. Structure factorielle de la traduction française de l'échelle d'impulsivité de Baratt (BIS-10) Rev Can Psychiatrie, 2000, 45, 156-65.
18. Berlin I, Givry-Steiner L, Lecrubier Y, et al. Measures of anhedonia and hedonic responses to sucrose in depressive and schizophrenic patients in comparison with healthy subjects. Eur Psychiatry, 1998, 13, 303-9.
19. Berlin I, Gorelick D. The French Law on "Protection of Persons Undergoing Biomédical Research": Implications for the U.S. J Law, Medicine and Ethics, 2003, 31, 434-41.
20. Holstein A, Plaschke A, Egberts EH. Clinical characterisation of severe hypoglycemia - a prospective population-based study. Exp Clin Endocrinol Diabetes, 2003, 111, 364-9.
21. Galan BE, Hoekstra JBL. Glucose counterregulation in type 2 diabetes mellitus. Diabet Medicine, 2001, 18, 519-27.
22. Spyer G, Hattersley AT, MacDonald IA, et al. Hypoglycaemic counter-regulation at normal blood glucose concentration in patients with well controlled type-2 diabetes. Lancet, 2000, 356, 1970-4.
23. Berlin I, Grimaldi A, Bosquet F, et al. Decreased beta-adrenergic sensitivity in insulin-dependent diabetic patients. J Clin Endocrinol Metab, 1986, 63, 262-5.
24. Veneman T, Mitrakou A, Mokan M, et al. The influence of obesity on neurophysiological responses to hypoglycamia (Abstract) Diabetologia, 1996, 39, Suppl 1, A220
25. Ford ES, Malarcher A, Herman W, et al. Smoking and diabetes: findings from the 1989 National Health Interview Survey. Diabetes Care, 1994, 17, 688-92.
26. Cryer PE, Haymond MW, Santiago JV, et al. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med, 1976, 295, 573-7.
27. Golden SH, Williams JE, Ford DE, et al. Depressive Symptoms and the Risk of Type 2 Diabetes. The Atherosclerosis Risk in Communities study. Diabetes Care, 2004, 27, 429-35.
28. Manson JE, Hu FB, Rich-Edwards JW, et al. A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. N Engl J Med, 1999, 341, 650-8.